What will your
story be?

Will you be part of our future as an investor, or do you have a question about Cassiopea? Please contact us at info@cassiopea.com for general inquiries.

For inquiries regarding press releases and media relations for Cassiopea please contact media@cassiopea.com.

Sign up to stay informed about now FDA-approved WINLEVI® (clascoterone) cream 1%, our first-in-class topical treatment.

Communications about WINLEVI are intended for US healthcare professionals only.

Don’t miss a thing by signing up here for updates.

All fields are required.